Sicel Technologies Receives Second Grant From Sisko Foundation

Sicel Technologies has received a second grant from the Sisko Foundation to further develop the company's implantable sensor technology. "This grant will help to enable the miniaturization of the fluorescence sensor so that it can be encapsulated for implantation at the site of a tumor," said Sicel's CEO, Robert Black. The company has proven feasibility of the device in pre-clinical studies, by measuring the uptake of Herceptin, a chemotherapeutic agent used in the treatment of breast cancer. The company markets a disposable surface dosimeter, OneDose, and anticipates receiving FDA clearance to market its first implantable radiation sensor in 2005.

dBusinessNews (http://triangle.dbusinessnews.com/shownews.php?newsid=12544&type_news=latest)